Essa Pharma Stock Price Prediction
| EPIX Stock | USD 6.40 0.08 1.27% |
Oversold Vs Overbought
45
Oversold | Overbought |
ESSA Pharma stock price prediction is an act of determining the future value of ESSA Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of ESSA Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of ESSA Pharma and does not consider all of the tangible or intangible factors available from ESSA Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with ESSA Pharma, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting ESSA Pharma's stock price prediction:EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (0.79) | EPS Estimate Next Year (1.05) | Wall Street Target Price 19 | EPS Estimate Current Quarter (0.17) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of ESSA Pharma based on different types of headlines from major news networks to social media. The ESSA stock price prediction module provides an analysis of price elasticity to changes in media outlook on ESSA Pharma over a specific investment horizon. Using ESSA Pharma hype-based prediction, you can estimate the value of ESSA Pharma from the perspective of ESSA Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ESSA Pharma using ESSA Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards ESSA using crowd psychology based on the activity and movement of ESSA Pharma's stock price.
ESSA Pharma Implied Volatility | 89.71 |
ESSA Pharma's implied volatility exposes the market's sentiment of ESSA Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ESSA Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ESSA Pharma stock will not fluctuate a lot when ESSA Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in ESSA Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in ESSA Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying ESSA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ESSA Pharma after-hype prediction price | USD 6.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ESSA |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ESSA Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ESSA Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of ESSA Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ESSA Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ESSA Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ESSA Pharma Estimiated After-Hype Price Volatility
In the context of predicting ESSA Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ESSA Pharma's historical news coverage. ESSA Pharma's after-hype downside and upside margins for the prediction period are 1.25 and 11.55, respectively. We have considered ESSA Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ESSA Pharma is slightly risky at this time. Analysis and calculation of next after-hype price of ESSA Pharma is based on 3 months time horizon.
ESSA Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ESSA Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ESSA Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ESSA Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 5.17 | 0.00 | 0.10 | 7 Events / Month | 4 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
6.40 | 6.40 | 0.00 |
|
ESSA Pharma Hype Timeline
ESSA Pharma is currently traded for 6.40. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.1. ESSA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.37%. %. The volatility of related hype on ESSA Pharma is about 1929.1%, with the expected price after the next announcement by competition of 6.30. About 79.0% of the company shares are held by institutions such as insurance companies. The book value of ESSA Pharma was currently reported as 3.19. The company recorded a loss per share of 0.59. ESSA Pharma last dividend was issued on the 25th of April 2018. The entity had 1:20 split on the 25th of April 2018. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out ESSA Pharma Basic Forecasting Models to cross-verify your projections.ESSA Pharma Related Hype Analysis
Having access to credible news sources related to ESSA Pharma's direct competition is more important than ever and may enhance your ability to predict ESSA Pharma's future price movements. Getting to know how ESSA Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ESSA Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CYTO | Altamira Therapeutics | (0.82) | 8 per month | 0.00 | (0.09) | 7.73 | (9.20) | 47.75 | |
| SMMT | Summit Therapeutics PLC | (0.37) | 11 per month | 6.81 | 0.03 | 9.89 | (10.82) | 35.30 | |
| ATXI | Avenue Therapeutics | (0.01) | 5 per month | 4.07 | (0.01) | 7.69 | (7.14) | 32.46 | |
| SPRO | Spero Therapeutics | 0.01 | 7 per month | 3.24 | (0.02) | 4.82 | (5.59) | 16.20 | |
| AGLE | Aeglea Bio Therapeutics | (0.15) | 6 per month | 0.00 | (0.02) | 9.44 | (9.40) | 20.08 |
ESSA Pharma Additional Predictive Modules
Most predictive techniques to examine ESSA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ESSA using various technical indicators. When you analyze ESSA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ESSA Pharma Predictive Indicators
The successful prediction of ESSA Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ESSA Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ESSA Pharma based on analysis of ESSA Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ESSA Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ESSA Pharma's related companies. | 2023 | 2024 (projected) | Net Current Asset Value | 3.6M | 3.2M | Days Payables Outstanding | 5.6K | 3.5K |
Story Coverage note for ESSA Pharma
The number of cover stories for ESSA Pharma depends on current market conditions and ESSA Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ESSA Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ESSA Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
ESSA Pharma Short Properties
ESSA Pharma's future price predictability will typically decrease when ESSA Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ESSA Pharma often depends not only on the future outlook of the potential ESSA Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ESSA Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.1 M | |
| Cash And Short Term Investments | 148.1 M |
Check out ESSA Pharma Basic Forecasting Models to cross-verify your projections. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for ESSA Stock analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Return On Assets (0.13) | Return On Equity (0.17) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.